Organization | Department of State for Health and Social Welfare, The Gambia

Department of State for Health and Social Welfare, The Gambia Report issue

Academic/Hospital Phase 2 Phase 3

Founded: Banjul Gambia (1965)

Organization Overview

First Clinical Trial

2002

NCT00120822

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2018

Timeline

NOW

Now

Alternative names

Department of State for Health and Social Welfare, The Gambia

Active Ingredients

Drugs in Phase 3 Trials (7)

amodiaquine (camoquin) (1 trial)

dihydroartemisinin (1 trial)

folic acid (1 trial)

menafrivac (1 trial)

piperaquine (1 trial)

pyrimethamine (daraprim) (3 trials)

sulfadoxine (3 trials)

Drugs in Phase 2 Trials (6)

10-valent Pneumococcal Conjugate Vaccine (Pneumosil) (1 trial)

gsk 2189242a (1 trial)

live oral poliovirus type 1, 2 and 3 (Trivalent oral polio vaccine - Sabin) (1 trial)

pneumococcal 13-valent conjugate vaccine (prevnar 13) (1 trial)

tritanrix-hepb (1 trial)

yellow fever vaccine 17d strain (1 trial)

Drugs in Other Trials (1)

vitamin a (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Anemia (Phase 3)

Malaria (Phase 3)

Meningitis (Phase 3)

Streptococcal Infections (Phase 2)

Overview

Highest Phase: Phase 3
# of Trials: 7
# of Trial APIs: 14